Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2013-01-05

Original market date: See footnote 1

1997-02-04

Product name:

BALMINIL DM + EXPECTORANT

DIN:

02201712 Electronic product monograph is not available

Company: 

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada  M1B 2K9

Class: 

Human

Dosage form(s):

Syrup

Route(s) of administration:

Oral

Number of active ingredient(s):

2

Schedule(s):

OTC  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

48:16.00   EXPECTORANTS ,  48:08.00   ANTITUSSIVES

Anatomical Therapeutic Chemical (ATC): See footnote 4

R05FA02  OPIUM DERIVATIVES AND EXPECTORANTS

Active ingredient group (AIG) number:See footnote 5

0200826001

List of active ingredient(s)
Active ingredient(s) Strength
DEXTROMETHORPHAN HYDROBROMIDE 15 MG / 5 ML
GUAIFENESIN 100 MG / 5 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: